Industry News
Selenium Supplements May Harm Not Help
Mar 01, 2012
According to a recent study, published Online First in The Lancet , selenium may help people who don't have enough of it, but for the people who have enough to begin with, selenium supplements may be detrimental to their health. It is shown in the study that taking the supplements may result in the development of type 2 diabetes... Read More
Breast Cancer Repeat Surgery Less Likely If Pathologist Present During First Operation
Mar 01, 2012
T he American Cancer Society estimates that this year alone, 229,060 Americans will be diagnosed with breast cancer and 39,920 patients will die from the disease. Almost one in three women with breast cancer surgery will require additional surgery, following a pathologic examination of their tumor... Read More
Breast Cancer Repeat Surgery Less Likely If Pathologist Present During First Operation
Mar 01, 2012
T he American Cancer Society estimates that this year alone, 229,060 Americans will be diagnosed with breast cancer and 39,920 patients will die from the disease. Almost one in three women with breast cancer surgery will require additional surgery, following a pathologic examination of their tumor... Read More
Resident Memory T Cells Prevalent In The Skin Are More Protective In Fighting Infection Than Central Memory T Cells In The Bloodstream
Mar 01, 2012
TREM Rx, Inc... Read More
Symptoms Of Myelofibrosis Relieved By Ruxolitinib
Mar 01, 2012
People with a blood cancer - myelofibrosis - can benefit from a drug called ruxolitinib, according to a randomized, double-blind, placebo-controlled clinical trial that included patients and researchers from the Stanford University School of Medicine... Read More
Symptoms Of Myelofibrosis Relieved By Ruxolitinib
Mar 01, 2012
People with a blood cancer - myelofibrosis - can benefit from a drug called ruxolitinib, according to a randomized, double-blind, placebo-controlled clinical trial that included patients and researchers from the Stanford University School of Medicine... Read More
Potential Solution To Melanoma's Resistance To Vemurafenib
Mar 01, 2012
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma. Vemurafenib resistance is characterized by a diminished apoptosis (programmed cancer cell death) response... Read More
Nurses Key In Helping New Cancer Patients Overcome Fears
Mar 01, 2012
Often faced with overwhelming anxiety, patients newly diagnosed with lung cancer can find themselves in distress, and new research recommends nurses play a key role in alleviating concerns, leading to a better quality of life for patients... Read More
Sleeping Pills Linked To Death And Cancer Risk
Mar 01, 2012
According to a study published in the online journal BMJ Open, some well-known sleeping medications have an elevated risk of death, even when taken only 18 times a year, and an increased risk of death when taken in large numbers. To determine their findings, the researchers analyzed survival rates of 10,500 volunteers who were taking sleeping pills for an average of 2... Read More
Another Mechanism Discovered By Which Sulforaphane Prevents Cancer
Mar 01, 2012
Researchers in the Linus Pauling Institute at Oregon State University have discovered yet another reason why the "sulforaphane"compound in broccoli and other cruciferous vegetables is so good for you - it provides not just one, but two ways to prevent cancer through the complex mechanism of epigenetics... Read More
Previous Page Next Page